STOCK TITAN

Traws Pharma: Jorey Chernett reports 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Jorey Chernett reports that he beneficially owned 0 shares of Traws Pharma, Inc. (TRAW) common stock as of September 30, 2026, equal to 0% of the class. The amendment is an exit filing.

Common shares beneficially owned 0 shares Jorey Chernett, as of September 30, 2026
Class ownership 0% Jorey Chernett, as of September 30, 2026
beneficially owned regulatory
"did not beneficially own any shares of Common Stock"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
dispositive power regulatory
"Sole power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TRAW shares did Jorey Chernett own?

Jorey Chernett beneficially owned 0 shares, or 0% of the class, as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68232V884

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 1 constitutes an exit filing for the Reporting Person, as the Reporting Person no longer beneficially any of the outstanding shares of the Issuer.


SCHEDULE 13G



Chernett Jorey
Signature:/s/ Jorey Chernett
Name/Title:Jorey Chernett
Date:11/16/2026

Keep reading